Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.9500
-0.05-4.99%
At close: -
$0.9800
0.033.16%
After Hours: 4:15 PM EDT
Comments
Loading...
RenovoRx (RNXT) Forecast
NewsEarningsRenovoRx (RNXT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
RenovoRx Stock Price, Quotes and Forecasts | NASDAQ:RNXT | Benzinga
Explore RenovoRx stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RNXT.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy RenovoRx (RNXT) stock?
You can purchase shares of RenovoRx (NASDAQ:RNXT) through any online brokerage.
Who are RenovoRx (RNXT) competitors?
Other companies in RenovoRx’s space includes: Estrella Immunopharma (NASDAQ:ESLA), bluebird bio (NASDAQ:BLUE), Intensity Therapeutics (NASDAQ:INTS), Coeptis Therapeutics (NASDAQ:COEP) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for RenovoRx (RNXT) stock?
RenovoRx has a consensus price target of $8.67.
What is the current price for RenovoRx (RNXT)?
The stock price for RenovoRx (NASDAQ: RNXT) is $0.98 last updated March 3, 2025 at 4:15 PM EST.
Does RenovoRx (RNXT) pay a dividend?
There are no upcoming dividends for RenovoRx.
When is RenovoRx (NASDAQ:RNXT) reporting earnings?
RenovoRx’s Q1 earnings are confirmed for Friday, May 9, 2025.
Is RenovoRx (RNXT) going to split?
There is no upcoming split for RenovoRx.
What sector and industry does RenovoRx (RNXT) operate in?
RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.